interaction with inhibitor of B (IB) proteins, predominantly IB-␣
. NF-B activity is induced in response to a variety of stimuli, including DNA-damaging anticancer agents [8] . In the context of DNA double strand breaks, NF-B is activated via ATM, which transmits the signal to the cytoplasmic IKK complex through phosphorylation of NEMO [11, 12] . NF-B can exert pleiotropic functions in the course of the DNA damage response [6] . For example, NF-B has been reported to transcriptionally activate anti-apoptotic proteins [13] , which may promote evasion of apoptosis in case of sublethal damage. Vice versa, NF-B has also been described to actively repress anti-apoptotic target genes upon treatment with certain chemotherapeutic agents, resulting in increased apoptosis [14] [15] [16] .
We [17] , indicating that NF-B does not simply orchestrate an anti-apoptotic program in glioblastoma as observed in a variety of other solid cancers or haematological malignancies [8] . [17] ), which is in line with previous reports [6, 15, 18] . Interestingly (Fig. 3A) . This pro-apoptotic function of NF-B was less prominent when U87MG cells were continuously incubated with cytotoxic drugs and was not observed in p53 mutant T98G cells (Fig. 3A and B [8] (Fig. S3B) (Fig. 7A-C) and enhanced TNF␣-induced apoptosis in A172 cells (Fig. 7D) . Importantly, NF-B inhibition significantly reduced DNA damage and apoptosis after pulse treatment with Doxorubicin ( Fig. 7E and F [14] [15] [16] . However, topoisomerase II poisons have also been reported to stimulate NF-B transcriptional activity [23, 24] 
previously reported that inhibition of NF-B does not translate into enhanced spontaneous or cytotoxic drug-induced apoptosis in glioblastoma cells

To gain further insights into the function of NF-B in glioblastoma, we investigated in the present study the role of drug-induced NF-B activity in the regulation of the DNA damage response.
Results
Generation of glioblastoma cell lines with stable inhibition of NF-B
To investigate the role of NF-B in the regulation of the DNA damage response in glioblastoma, we generated glioblastoma cell lines, which stably express the dominant-negative superrepressor mutant IB␣-S(32, 36)A (IB␣-SR) or empty vector control. IB␣-SR is resistant to proteasomal degradation, because it cannot be phosphorylated at the two phosphorylation sites serine 32/36, and thus blocks NF-B activation. For this purpose, we selected two prototypical glioblastoma cell lines, i.e. U87MG and T98G, which harbour p53 wild-type and p53 mutant, respectively. Retroviral transduction resulted in strong ectopic expression of IB␣-SR (Fig. 1A). To control functionality of mutant IB␣-SR protein, we assessed NF-B DNA binding activity by electrophoretic mobility shift assay (EMSA) and apoptosis induction in response to the pro-inflammatory cytokine tumour necrosis factor (TNF)␣, a prototypical model of apoptosis inhibition by NF-B [8]. Ectopic expression of IB␣-SR substantially reduced basal as well as TNF␣-or Doxorubicin-stimulated NF-B DNA binding activity (Fig. 1B). Further, overexpression of IB␣-SR blocked TNF␣-triggered NF-B transcriptional activity, which in turn significantly increased TNF␣-induced apoptosis (Fig. 1C and D). This demonstrates that stable overexpression of IB␣-SR results in potent blockade of the NF-B pathway in a prototype model of the anti-apoptotic function of NF-B in both U87MG and T98G glioblastoma cells.
DNA intercalators trigger NF-B DNA-binding activity and transcriptional activation
NF-B enhances Doxorubicin-induced apoptosis in a p53-independent manner
NF-B is known for its anti-apoptotic action [21] and has for example in glioblastoma cells been associated with reduced cytotoxicity of the alkylating agent BCNU, the platin compound carboplatin and the topoisomerase I inhibitor SN-38 [22]. More recently, NF-B has also been linked to the induction of apoptosis in the context of DNA-damaging anticancer agents [6]. The proapoptotic function of NF-B in response to topoisomerase II inhibitors or UVC irradiation has been attributed to active repression of anti-apoptotic genes by the NF-B subunit p65 (RelA) because of lack of key post-translational modifications that are required for the role of p65 (RelA) as transcriptional activator
. In glioblastoma cells -as demonstrated in the present study -treatment with topoisomerase II inhibitors that also intercalate into the DNA results in the production of NF-B complexes that are competent not only for DNA binding but also for transcriptional activation from NF-B reporter constructs as well as for induction of apoptosis. It is interesting to note that a pro-apoptotic role of NF-B has also been described in several models of neuronal cell death. For example, neuronal death in response to ischemia, glutamate, or NMDA receptor triggering has been reported to require NF-B [25-28]. Further, dopamine-induced cell death of pheochromocytoma cells, doxorubicin-, fenretinide-or betulinic acid-induced apoptosis of neuroblastoma cells or cell death triggered by MMP-9 inhibition in medulloblastoma cells have all been shown to depend on NF-B activation [29-33]. A pro-apoptotic role of NF-B in neuronal cells is further supported by data showing that anti-inflammatory drugs such as aspirin prevent neuronal cell death via inhibition of NF-B [34]. These reports indicate that
Fig. 6 NF-B enhances DNA intercalator-induced DNA damage. (A) U87MG (left panels) or T98G (right panels) cells stably transduced with control vector (white bars) or a vector containing IB␣-SR (black bars) were continuously treated for indicated times with 0.8 g/ml Doxorubicin (U87MG) or 1 g/ml Doxorubicin (T98G), 2 M Daunorubicin or 2.5 M Mitoxantrone and DNA damage was assayed by Comet assay and is displayed as Olive Tail Moment. (B) U87MG (left panels) or T98G (right panels) cells stably transduced with control vector (white bars) or a vector containing IB␣-SR (black
and 24 hrs by Comet assay and is displayed as Olive Tail Moment (C), apoptosis was assessed by FACS analysis of DNA fragmentation of propidium iodide stained nuclei (D). In (E) and (F), U87MG cells stably transduced with control vector (white bars) or a vector containing IB␣-SR (black bars) were treated for 18 hrs with 0.8 g/ml Doxorubicin in the absence or presence of 50 M zVAD.fmk, followed by a complete exchange of medium and re-addition of zVAD.fmk. DNA damage was assayed after 24 hrs by Comet assay and is displayed as Olive Tail Moment (E), apoptosis was assessed by FACS analysis of DNA fragmentation of propidium iodide stained nuclei (D). Median (A-C, E) or mean (D,
F
NF-B: tumour suppressor or promoter in glioblastoma?
While NF-B has traditionally been viewed as a tumour promoter, there is mounting evidence that it can also act as tumour suppressor under certain circumstances [38] . By demonstrating that NF-B increases apoptosis in glioblastoma cells, our findings may point to a tumour suppressor rather than a tumour promoter function of NF-B in glioblastoma. However, NF-B-mediated increase in DNA damage may also contribute to genetic instability, thereby promoting tumour progression. In clinical specimens from patients with glioblastoma, increased NF-B activity has been detected [39] [40] [41] [42] [43] [44] , but so far has only been correlated with higher tumour grade and adverse patients' prognosis in one recent study [44] . Thus, the functional relevance of NF-B activity in glioblastoma, e.g. in distinct stages of tumour progression, awaits further investigations.
In conclusion, by demonstrating that NF-B promotes DNA damage and apoptosis upon treatment with DNA intercalators, our findings provide novel insights into the role of NF-B in the control of the DNA damage response in glioblastoma. 
induction of NF-B transcriptional activity. Fold increase in luciferase activity relative to unstimulated control is shown. (D), Enhancement of TNF␣-induced apoptosis by NF-B inhibition. A172 cells transduced with control vector (white bars) or a vector containing IB␣-SR (black bars) were left untreated (-TNF␣) or were treated with 50 ng/ml TNF␣ for 48 hrs (ϩTNF␣). Apoptosis was determined by FACS analysis of DNA-fragmentation of propidium iodide stained nuclei. (E), NF-B promotes
Production of retrovirus and retroviral transduction
The pCFG5-IEGZ retroviral vector system, as described by [46] , was used to infect U87MG and T98G glioblastoma cells as previously described [17] . [47] was cloned into pRETRO-SUPER as previously described [48] . A sequence with no corresponding part in the human genome (gatcatgtagatacgctca) was used as control. Stable bulk cultures were generated by retroviral transduction and selected with puromycin (0.5 g/ml).
RNA interference
Cells were transfected with siRNA using TransMessenger transfection reagent (Qiagen, Hilden, Germany) as previously described [49] 
Western blot analysis
Western blotting was performed as previously described [33] 
